|

Acetaminophen-Mannitol Injection and Postoperative Delirium

RECRUITINGPhase 4Sponsored by Xiangya Hospital of Central South University
Actively Recruiting
PhasePhase 4
SponsorXiangya Hospital of Central South University
Started2026-02-02
Est. completion2027-01-31
Eligibility
Age60 Years+
Healthy vol.Accepted

Summary

The aim of this multicenter randomized controlled study is to evaluate the effect of an intravenous acetaminophen-mannitol opioid-sparing analgesic strategy on the cumulative incidence of POD, compared with an intravenous sufentanil-based opioid analgesic strategy.

Eligibility

Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 60 years;
* Admitted to ICU after a noncardiac surgical procedure
* Signed informed consent form

Exclusion Criteria:

Patients who meet any of the following criteria will be excluded.

* Preoperative medical history: schizophrenia, epilepsy, Parkinson's disease, end stage renal disease, or end stage liver disease.
* Inability to communicate preoperatively due to coma, severe dementia, or language disorder.
* Patients with traumatic brain injury or undergoing neurosurgical procedures.
* Positive screening result for drugs of abuse (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methamphetamine, methadone, or methylenedioxymethamphetamine).
* Participation in another clinical study within 30 days prior to surgery, or planned concurrent participation in another clinical study.
* Positive preoperative CAM-ICU assessment indicating delirium.
* Occurrence of intraoperative or postoperative complications before randomization, and the investigator deems the subject unsuitable for study participation.
* Hepatic dysfunction at screening, defined as ALT or AST \>3× the local laboratory upper limit of normal (ULN).
* Intolerance or contraindication to acetaminophen or the protocol analgesics.

Conditions2

Heart DiseasePostoperative Delirium

Interventions2

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.